Aprea Therapeutics reports Dec 31, 2024 cash balance of $22.8M

Aprea Therapeutics, Inc.

Cash and cash equivalents of $22.8M as of December 31, 2024 (preliminary, unaudited).
Disclosed via corporate presentation posted to company website on January 13, 2025.
Balance subject to completion of fiscal 2024 year-end financial statements.
No other financial results or guidance provided in the presentation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.